The effects of phenoxodiol on the cell cycle of prostate cancer cell lines

[1] Montero A(2005)Docetaxel for treatment of solid tumours: a systematic review of clinical data Lancet Oncol 6 229-239

[2] Fossella F(2006)Bortezomib inhibits docetaxel-induced apoptosis via a p21-dependent mechanism in human prostate cancer cells Mol Cancer Ther 5 2043-2050

[3] Hortobagyi G(2000)The hallmarks of cancer Cell 100 57-70

[4] Valero V(2003)Reappraisal of serum starvation, the restriction point, G0, and G1 phase arrest points FASEB J 17 333-340

[5] Canfield SE(1974)A restriction point for control of normal animal cell proliferation Proc Natl Acad Sci U S A 71 1286-1290

[6] Zhu K(2000)Risks and benefits of taxanes in breast and ovarian cancer Drug Saf 23 401-428

[7] Williams SA(2011)Resistance to docetaxel-induced apoptosis in prostate cancer cells by p38/p53/p21 signaling Prostate 71 1158-1166

[8] McConkey DJ(2002)Phenoxodiol (2H-1-benzopyran-7-0,1,3-(4-hydroxyphenyl)), a novel isoflavone derivative, inhibits DNA topoisomerase II by stabilizing the cleavable complex Anticancer Res 22 2581-2585

[9] Hanahan D(2009)Phenoxodiol treatment alters the subsequent response of ENOX2 (tNOX) and growth of hela cells to paclitaxel and cisplatin Mol Biotechnol 42 100-109

[10] Weinberg RA(2012)Cytotoxic effects of the novel isoflavone, phenoxodiol, on prostate cancer cell lines J Biosci 37 73-84

[1] Montero A(2005)Docetaxel for treatment of solid tumours: a systematic review of clinical data Lancet Oncol 6 229-239

[2] Fossella F(2006)Bortezomib inhibits docetaxel-induced apoptosis via a p21-dependent mechanism in human prostate cancer cells Mol Cancer Ther 5 2043-2050

[3] Hortobagyi G(2000)The hallmarks of cancer Cell 100 57-70

[4] Valero V(2003)Reappraisal of serum starvation, the restriction point, G0, and G1 phase arrest points FASEB J 17 333-340

[5] Canfield SE(1974)A restriction point for control of normal animal cell proliferation Proc Natl Acad Sci U S A 71 1286-1290

[6] Zhu K(2000)Risks and benefits of taxanes in breast and ovarian cancer Drug Saf 23 401-428

[7] Williams SA(2011)Resistance to docetaxel-induced apoptosis in prostate cancer cells by p38/p53/p21 signaling Prostate 71 1158-1166

[8] McConkey DJ(2002)Phenoxodiol (2H-1-benzopyran-7-0,1,3-(4-hydroxyphenyl)), a novel isoflavone derivative, inhibits DNA topoisomerase II by stabilizing the cleavable complex Anticancer Res 22 2581-2585

[9] Hanahan D(2009)Phenoxodiol treatment alters the subsequent response of ENOX2 (tNOX) and growth of hela cells to paclitaxel and cisplatin Mol Biotechnol 42 100-109

[10] Weinberg RA(2012)Cytotoxic effects of the novel isoflavone, phenoxodiol, on prostate cancer cell lines J Biosci 37 73-84